Pae, Chi-Un <br/><br/>
Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: a 12-week prospective open-label multicentre study.  [electronic resource] 

 -  International clinical psychopharmacology  Nov 2013 
 - 322-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5857 
<br/><br/><label>Standard No.: </label>10.1097/YIC.0b013e3283643728  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antidepressive Agents--administration & dosage<br/>Aripiprazole<br/>Chronic Disease<br/>Depressive Disorder, Major--diagnosis<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Prospective Studies<br/>Quinolones--administration & dosage<br/>Secondary Prevention<br/>Treatment Outcome